在氨苄西林和头孢呋辛的选择性压力下,流感嗜血杆菌菌株中导致 PBP3 氨基酸置换的 ftsI 基因突变的演变

IF 4.5 3区 医学 Q1 MICROBIOLOGY
Vladislav Jakubu , Iveta Vrbova , Ibrahim Bitar , Marketa Cechova , Lucia Malisova , Helena Zemlickova
{"title":"在氨苄西林和头孢呋辛的选择性压力下,流感嗜血杆菌菌株中导致 PBP3 氨基酸置换的 ftsI 基因突变的演变","authors":"Vladislav Jakubu ,&nbsp;Iveta Vrbova ,&nbsp;Ibrahim Bitar ,&nbsp;Marketa Cechova ,&nbsp;Lucia Malisova ,&nbsp;Helena Zemlickova","doi":"10.1016/j.ijmm.2024.151626","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Aminopenicillins are recommended agents for non-invasive <em>Haemophilus influenzae</em> infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the <em>ftsI</em> gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of <em>H. influenzae</em> strains with the non-enzymatic mechanism of resistance.</p></div><div><h3>Objectives</h3><p>The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in <em>H. influenzae</em> strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3.</p></div><div><h3>Methods</h3><p>30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing.</p></div><div><h3>Results</h3><p>On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin.</p></div><div><h3>Conclusions</h3><p>Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic.</p></div>","PeriodicalId":50312,"journal":{"name":"International Journal of Medical Microbiology","volume":"316 ","pages":"Article 151626"},"PeriodicalIF":4.5000,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1438422124000304/pdfft?md5=86397ef66bdbd21e557fa9a191521b10&pid=1-s2.0-S1438422124000304-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Evolution of mutations in the ftsI gene leading to amino acid substitutions in PBP3 in Haemophilus influenzae strains under the selective pressure of ampicillin and cefuroxime\",\"authors\":\"Vladislav Jakubu ,&nbsp;Iveta Vrbova ,&nbsp;Ibrahim Bitar ,&nbsp;Marketa Cechova ,&nbsp;Lucia Malisova ,&nbsp;Helena Zemlickova\",\"doi\":\"10.1016/j.ijmm.2024.151626\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Aminopenicillins are recommended agents for non-invasive <em>Haemophilus influenzae</em> infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the <em>ftsI</em> gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of <em>H. influenzae</em> strains with the non-enzymatic mechanism of resistance.</p></div><div><h3>Objectives</h3><p>The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in <em>H. influenzae</em> strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3.</p></div><div><h3>Methods</h3><p>30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing.</p></div><div><h3>Results</h3><p>On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin.</p></div><div><h3>Conclusions</h3><p>Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic.</p></div>\",\"PeriodicalId\":50312,\"journal\":{\"name\":\"International Journal of Medical Microbiology\",\"volume\":\"316 \",\"pages\":\"Article 151626\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-06-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1438422124000304/pdfft?md5=86397ef66bdbd21e557fa9a191521b10&pid=1-s2.0-S1438422124000304-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medical Microbiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1438422124000304\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1438422124000304","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景氨基青霉素类是治疗非侵袭性流感嗜血杆菌感染的推荐药物。对β-内酰胺类药物产生耐药性的机制之一是青霉素结合蛋白 3(PBP3)的转肽酶区域发生了改变,而这是由 ftsI 基因突变引起的。研究表明,接触β-内酰胺类药物会刺激具有非酶耐药机制的流感嗜血杆菌菌株发病率的增加。我们的研究旨在比较氨苄西林和头孢呋辛在流感杆菌菌株中的变异潜力、最低抑菌浓度的测定以及变异随时间的演变,重点是 PBP3 中的氨基酸替代。最低抑菌浓度最高增加了 32 倍。传代 15 天后,PBP3 开始出现替代。在 PBP3 中,头孢呋辛与氨苄西林引起的替代不同。抗生素在体外的选择压力产生了捷克共和国临床菌株中不会出现的变异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evolution of mutations in the ftsI gene leading to amino acid substitutions in PBP3 in Haemophilus influenzae strains under the selective pressure of ampicillin and cefuroxime

Background

Aminopenicillins are recommended agents for non-invasive Haemophilus influenzae infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the ftsI gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of H. influenzae strains with the non-enzymatic mechanism of resistance.

Objectives

The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in H. influenzae strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3.

Methods

30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing.

Results

On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin.

Conclusions

Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.70
自引率
0.00%
发文量
18
审稿时长
45 days
期刊介绍: Pathogen genome sequencing projects have provided a wealth of data that need to be set in context to pathogenicity and the outcome of infections. In addition, the interplay between a pathogen and its host cell has become increasingly important to understand and interfere with diseases caused by microbial pathogens. IJMM meets these needs by focussing on genome and proteome analyses, studies dealing with the molecular mechanisms of pathogenicity and the evolution of pathogenic agents, the interactions between pathogens and host cells ("cellular microbiology"), and molecular epidemiology. To help the reader keeping up with the rapidly evolving new findings in the field of medical microbiology, IJMM publishes original articles, case studies and topical, state-of-the-art mini-reviews in a well balanced fashion. All articles are strictly peer-reviewed. Important topics are reinforced by 2 special issues per year dedicated to a particular theme. Finally, at irregular intervals, current opinions on recent or future developments in medical microbiology are presented in an editorial section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信